EUVIMEDEUVIMED entdecken
Crossref

Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach

Po-Liang Cheng, Tzu-Hung Hsiao, Chung-Hsing Chen iD, Miao-Neng Hung, Pei-Pei Jhan, Li-Wen Lee, Ting-Shuan Wu, Jia-Rung Tsai, Chieh-Lin Jerry Teng iD

Hematological Oncology · 2023

DOI: 10.1002/hon.3129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2023. Verfasst von Po-Liang Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Taichung Veterans General Hospital, Yang Ming Chiao Tung University, National Health Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our previous study demonstrated that myc, mitochondrial oxidative phosphorylation, mTOR, and stemness are independently responsible for chemoresistance in acute myeloid leukemia (AML) cells. This study aimed to identify potential mechanisms of chemoresistance of the “7 + 3” induction in AML by using a single‐cell RNA sequencing (scRNA‐seq) approach. In the present study, 13 untreated patients with de novo AML were enrolled and stratified into two groups: complete remission (CR; n = 8) and non‐CR ( n = 5). Single‐cell RNA sequencing was used to analyze genetic profiles of 28,950 AML cells from these patients; results were validated using a previously published bulk RNA‐seq dataset. Our study results showed chemoresistant AML cells had premature accumulation during early hematopoiesis. Hematopoietic stem cell‐like cells from the non‐CR group expressed more leukemic stem cell markers (CD9, CD82, IL3RA, and IL1RAP) than those from the CR group. Chemoresistant progenitor cells had impaired myeloid differentiation owing to early arrest of hematopoiesis. Notably, AML cells analyzed by scRNA‐seq and bulk RNA‐seq harbored a comparable myeloid lineage cell fraction, which internally validated our results. Using the TCGA database, our analysis demonstrated that patients with AML with higher expression of chemoresistant genetic markers (IL3RA and IL1RAP) had a worse overall survival ( p < 0.01 for IL3RA; p < 0.05 for IL1RAP). In conclusion, AML cells responsive and resistant to the “7 + 3” induction were derived from a diverse cancerous hematopoietic stem cell population, as indicated by the specific genetic biomarkers obtained using scRNA‐seq approach. Furthermore, arrest of hematopoiesis was shown to occur earlier in chemoresistant AML cells, furthering the current understanding of chemoresistance in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmLeukemia, Myeloid, AcuteHumansPrognosisHematopoietic Stem CellsSequence Analysis, RNA

Stichwörter der Autor:innen

acute myeloid leukemiachemoresistanceleukemia stem cellssingle-cell RNA-seq

Autor:innen und Institutionen

  • Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Research Center for Biomedical Science and Engineering, National Tsing Hua University, Hsinchu, Taiwan.
  • Department of Public Health, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan.
  • National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

ORCID-Profile: Chung-Hsing Chen, Chieh-Lin Jerry Teng

Förderung

  • Taichung Veterans General Hospital
  • Yang Ming Chiao Tung University
  • National Health Research Institutes
  • National Science and Technology Council

Zitieren

APA

Cheng, P. L., Hsiao, T. H., Chen, C. H., Hung, M. N., Jhan, P. P., Lee, L. W., Wu, T. S., Tsai, J. R., & Teng, C. J. (2023). Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach. Hematological Oncology. https://doi.org/10.1002/hon.3129

Vancouver

Cheng PL, Hsiao TH, Chen CH, Hung MN, Jhan PP, Lee LW, et al. Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach. Hematological Oncology. 2023. doi:10.1002/hon.3129

BibTeX
@article{Cheng2023,
  author = {Cheng, Po-Liang and Hsiao, Tzu-Hung and Chen, Chung-Hsing and Hung, Miao-Neng and Jhan, Pei-Pei and Lee, Li-Wen and Wu, Ting-Shuan and Tsai, Jia-Rung and Teng, Chieh-Lin Jerry},
  title = {Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach},
  journal = {Hematological Oncology},
  year = {2023},
  doi = {10.1002/hon.3129}
}
Kostenlos starten →